Dynavax Technologies (NASDAQ:DVAX) reported quarterly earnings of $0.14 per share which beat the analyst consensus estimate of $0.09 by 60.92 percent. This is a 75 percent increase over earnings of $0.08 per share from the same period last year. The company reported quarterly sales of $91.872 million which beat the analyst consensus estimate of $85.914 million by 6.93 percent. This is a 24.50 percent increase over sales of $73.795 million the same period last year.